Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by abrdn plc

abrdn plc trimmed its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 26.2% in the fourth quarter, HoldingsChannel.com reports. The fund owned 259,216 shares of the biotechnology company’s stock after selling 92,159 shares during the period. abrdn plc’s holdings in Axon Enterprise were worth $155,099,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in AXON. Financial Life Planners acquired a new stake in Axon Enterprise in the fourth quarter valued at $480,000. Rice Partnership LLC raised its position in Axon Enterprise by 19.9% in the 4th quarter. Rice Partnership LLC now owns 602 shares of the biotechnology company’s stock valued at $358,000 after purchasing an additional 100 shares during the last quarter. Chicago Capital LLC boosted its stake in shares of Axon Enterprise by 8.2% during the fourth quarter. Chicago Capital LLC now owns 23,358 shares of the biotechnology company’s stock worth $13,882,000 after buying an additional 1,775 shares during the period. GPS Wealth Strategies Group LLC grew its stake in shares of Axon Enterprise by 74.1% in the 4th quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company’s stock valued at $56,000 after purchasing an additional 40 shares during the last quarter. Finally, U.S. Capital Wealth Advisors LLC raised its position in Axon Enterprise by 53.2% during the 4th quarter. U.S. Capital Wealth Advisors LLC now owns 2,032 shares of the biotechnology company’s stock worth $1,208,000 after buying an additional 706 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now directly owns 6,929 shares in the company, valued at $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Michael Garnreiter sold 1,000 shares of the firm’s stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $639.69, for a total transaction of $639,690.00. Following the transaction, the director now owns 24,259 shares of the company’s stock, valued at approximately $15,518,239.71. This trade represents a 3.96 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 50,545 shares of company stock worth $30,721,337. 5.70% of the stock is currently owned by insiders.

Axon Enterprise Stock Up 0.9 %

NASDAQ:AXON opened at $658.11 on Tuesday. The company has a market capitalization of $50.18 billion, a price-to-earnings ratio of 170.05, a price-to-earnings-growth ratio of 6.54 and a beta of 1.05. The stock has a 50-day simple moving average of $620.41 and a 200 day simple moving average of $486.16. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. Axon Enterprise, Inc. has a one year low of $252.20 and a one year high of $698.67.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the company. Northland Securities increased their price objective on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research report on Monday, November 11th. The Goldman Sachs Group boosted their target price on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research report on Monday, January 27th. Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. TD Cowen began coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price target on the stock. Finally, Needham & Company LLC lifted their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. One research analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat.com, Axon Enterprise has an average rating of “Moderate Buy” and a consensus target price of $524.85.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.